| Structural cells are key regulators of organ-specific immune responses T Krausgruber, N Fortelny, V Fife-Gernedl, M Senekowitsch, LC Schuster, ... Nature 583 (7815), 296-302, 2020 | 387 | 2020 |
| Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 E Alm, EK Broberg, T Connor, EB Hodcroft, AB Komissarov, ... Eurosurveillance 25 (32), 2001410, 2020 | 269 | 2020 |
| Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2 A Popa, JW Genger, MD Nicholson, T Penz, D Schmid, SW Aberle, ... Science translational medicine 12 (573), eabe2555, 2020 | 243 | 2020 |
| SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses B Agerer, M Koblischke, V Gudipati, LF Montaño-Gutierrez, M Smyth, ... Science immunology 6 (57), eabg6461, 2021 | 177 | 2021 |
| The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection C Schliehe, EK Flynn, B Vilagos, U Richson, S Swaminathan, B Bosnjak, ... Nature immunology 16 (1), 67-74, 2015 | 140 | 2015 |
| Epigenetic memory of coronavirus infection in innate immune cells and their progenitors JG Cheong, A Ravishankar, S Sharma, CN Parkhurst, SA Grassmann, ... Cell 186 (18), 3882-3902. e24, 2023 | 131 | 2023 |
| Systemic immunometabolism: challenges and opportunities A Lercher, H Baazim, A Bergthaler Immunity 53 (3), 496-509, 2020 | 103 | 2020 |
| Type I interferon signaling disrupts the hepatic urea cycle and alters systemic metabolism to suppress T cell function A Lercher, A Bhattacharya, AM Popa, M Caldera, MF Schlapansky, ... Immunity 51 (6), 1074-1087. e9, 2019 | 96 | 2019 |
| AIF-regulated oxidative phosphorylation supports lung cancer development S Rao, L Mondragón, B Pranjic, T Hanada, G Stoll, T Köcher, P Zhang, ... Cell research 29 (7), 579-591, 2019 | 91 | 2019 |
| CD8+ T cells induce cachexia during chronic viral infection H Baazim, M Schweiger, M Moschinger, H Xu, T Scherer, A Popa, ... Nature immunology 20 (6), 701-710, 2019 | 81 | 2019 |
| Environmental arginine controls multinuclear giant cell metabolism and formation JS Brunner, L Vulliard, M Hofmann, M Kieler, A Lercher, A Vogel, ... Nature communications 11 (1), 431, 2020 | 54 | 2020 |
| 24-Norursodeoxycholic acid reshapes immunometabolism in CD8+ T cells and alleviates hepatic inflammation C Zhu, N Boucheron, AC Müller, P Májek, T Claudel, E Halilbasic, ... Journal of hepatology 75 (5), 1164-1176, 2021 | 50 | 2021 |
| The ERBB-STAT3 axis drives Tasmanian devil facial tumor disease L Kosack, B Wingelhofer, A Popa, A Orlova, B Agerer, B Vilagos, P Majek, ... Cancer Cell 35 (1), 125-139. e9, 2019 | 49 | 2019 |
| The PI3K pathway preserves metabolic health through MARCO-dependent lipid uptake by adipose tissue macrophages JS Brunner, A Vogel, A Lercher, M Caldera, A Korosec, M Pühringer, ... Nature Metabolism 2 (12), 1427-1442, 2020 | 34 | 2020 |
| The versatility of external quality assessment for the surveillance of laboratory and in vitro diagnostic performance: SARS-CoV-2 viral genome detection in Austria C Buchta, JV Camp, J Jovanovic, P Chiba, E Puchhammer-Stöckl, ... Clinical Chemistry and Laboratory Medicine (CCLM) 59 (10), 1735-1744, 2021 | 21 | 2021 |
| Human tripartite motif protein 52 is required for cell context-dependent proliferation S Benke, B Agerer, L Haas, M Stöger, A Lercher, L Gabler, I Kiss, ... Oncotarget 9 (17), 13565, 2018 | 20 | 2018 |
| Characterization of host proteins interacting with the lymphocytic choriomeningitis virus L protein K Khamina, A Lercher, M Caldera, C Schliehe, B Vilagos, M Sahin, ... PLoS pathogens 13 (12), e1006758, 2017 | 20 | 2017 |
| Hepatocyte-intrinsic type I interferon signaling reprograms metabolism and reveals a novel compensatory mechanism of the tryptophan-kynurenine pathway in viral hepatitis A Lercher, AM Popa, C Viczenczova, L Kosack, K Klavins, B Agerer, ... PLoS Pathogens 16 (10), e1008973, 2020 | 17 | 2020 |
| The lipid-sensor TREM2 aggravates disease in a model of LCMV-induced hepatitis L Kosack, R Gawish, A Lercher, B Vilagos, A Hladik, K Lakovits, ... Scientific reports 7 (1), 11289, 2017 | 17 | 2017 |
| Metabolic drug survey highlights cancer cell dependencies and vulnerabilities T Pemovska, JW Bigenzahn, I Srndic, A Lercher, A Bergthaler, ... Nature Communications 12 (1), 7190, 2021 | 14 | 2021 |
Andreas BergthalerMedical University of Vienna // CeMM, Austrian Academy of Sciencesmeduniwien.ac.at üzerinde doğrulanmış e-posta adresine sahip